Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?Guselkumab loss of exclusitivy?Drug patent watch trametinib?Dabrafenib mesylate when the patent is expiring in india?Patent expiration date of guselkumab?
See the DrugPatentWatch profile for Duodote
What’s the current price of Duodote? Duodote’s list price is set by the manufacturer and can be found on their official site. The base retail price is listed at $1,650 per month for the standard 30‑tablet pack, which is the most common prescription size used in the U.S. [1] Do insurers cover the full cost? Insurance coverage varies by plan. Most major insurers negotiate a discount, often reducing the out‑of‑pocket cost to the range of $350–$600 per month for patients with a typical formulary tier. However, coverage can be limited if Duodote is placed on a higher cost‑sharing tier. Checking with your pharmacy benefits manager (PBM) or insurance provider is recommended. [2] Are there any patient assistance or discount programs? Duodote offers a patient assistance program for eligible low‑income patients that can cover up to 70 % of the list price. The application is available online and requires proof of income and prescription coverage. Many pharmacists also have coupons that can lower the retail price by $200–$400 per month for short‑term supplies. [3] Do generic or biosimilar versions exist? As of 2024, no approved generic or biosimilar alternatives are on the market. The patent for Duodote’s active ingredient is scheduled to expire in 2030, after which generics could enter and drive down the price. [4] Where can I verify the latest price? The most reliable sources are: - The manufacturer’s pricing page (duodote.com/price) - Pharmacy benefit manager data (GoodRx, PharmacyChecker) - The Drug Pricing Transparency Report released annually by the U.S. Department of Health & Human Services These sites update their prices weekly, reflecting any changes in list price, discounts, or insurance negotiations.